0000950103-22-006474.txt : 20220415
0000950103-22-006474.hdr.sgml : 20220415
20220415184905
ACCESSION NUMBER: 0000950103-22-006474
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20220415
DATE AS OF CHANGE: 20220415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legorreta Pablo G.
CENTRAL INDEX KEY: 0001507678
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 22830831
MAIL ADDRESS:
STREET 1: 110 E 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: Legorreta Pablo
DATE OF NAME CHANGE: 20101213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4/A
1
dp171118_4a.xml
FORM 4/A
X0306
4/A
2020-06-15
2020-06-22
0
0001802768
Royalty Pharma plc
RPRX
0001507678
Legorreta Pablo G.
C/O ROYALTY PHARMA PLC
110 E. 59TH STREET
NEW YORK
NY
10022
1
1
1
0
CEO, Chairman of the Board
ICAI Interests
0
2020-06-15
4
A
0
1719074
0
A
Limited Partnership interests in RPI US Partners 2019, LP
1719074
1719074
I
By Legorreta Investments LLC
The Reporting Person acquired beneficial ownership of Class B Interests in Royalty Pharma Holdings Ltd, ("Holdings") and became entitled to indirect rights to exchange such Class B Interests for Class A Ordinary Shares of the Issuer in connection with a reorganization prior to closing of the Issuer's initial public offering (as more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-238632)). The reorganization involved the exchange of interests in Royalty Pharma Investments 2019 ICAV held by RPI US Partners 2019, LP ("RPI US LP") and RPI International Holdings 2019, LP ("RPI Intl. LP") for interests in Holdings. The reorganization and the acquisition of these exchange rights occurred on June 15, 2020.
Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
These ICAI Interests represent a grant of up to 1,719,074 RPI US LP Interests and expire on December 15, 2023. The full number of RPI US LP Interests is issuable in respect of these ICAI Interests if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The number of RPI US LP Interests issuable in respect of these ICAI Interests scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.
This amendment to Form 4 is being filed to correct the terms and the number of ICAI Interests that was incorrectly reported on the Reporting Person's original Form 4 due to an inadvertent administrative error.
/s/ Jason Mehar, as Attorney-in-Fact, for Pablo G. Legorreta
2022-04-15